Market Closed -
Nasdaq
04:00:00 2024-05-16 pm EDT
|
5-day change
|
1st Jan Change
|
11.4
USD
|
-1.98%
|
|
-0.96%
|
0.00%
|
Fiscal Period: December |
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,953
|
-
|
-
|
Enterprise Value (EV)
1 |
4,277
|
4,149
|
3,920
|
P/E ratio
|
14.3
x
|
11.2
x
|
9.3
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.18
x
|
0.17
x
|
0.16
x
|
EV / Revenue
|
0.4
x
|
0.37
x
|
0.32
x
|
EV / EBITDA
|
7.58
x
|
6.75
x
|
5.88
x
|
EV / FCF
|
21.6
x
|
17.8
x
|
-
|
FCF Yield
|
4.63%
|
5.63%
|
-
|
Price to Book
|
1.25
x
|
1.11
x
|
0.97
x
|
Nbr of stocks (in thousands)
|
171,320
|
-
|
-
|
Reference price
2 |
11.40
|
11.40
|
11.40
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
8,826
|
10,609
|
11,308
|
12,301
|
EBITDA
1 |
-
|
537.8
|
564.4
|
614.8
|
666.8
|
EBIT
1 |
-
|
335.5
|
355.5
|
377
|
426.1
|
Operating Margin
|
-
|
3.8%
|
3.35%
|
3.33%
|
3.46%
|
Earnings before Tax (EBT)
1 |
-
|
-177.4
|
146.6
|
194.5
|
248.6
|
Net income
1 |
-53.91
|
-154.6
|
147.9
|
217
|
279.2
|
Net margin
|
-
|
-1.75%
|
1.39%
|
1.92%
|
2.27%
|
EPS
2 |
-7.180
|
-1.310
|
0.7996
|
1.014
|
1.226
|
Free Cash Flow
1 |
-
|
137.3
|
197.9
|
233.6
|
-
|
FCF margin
|
-
|
1.56%
|
1.87%
|
2.07%
|
-
|
FCF Conversion (EBITDA)
|
-
|
25.52%
|
35.07%
|
38%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
133.83%
|
107.69%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/28/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
2,375
|
2,577
|
2,616
|
2,656
|
2,759
|
2,786
|
2,834
|
EBITDA
1 |
142.6
|
130.5
|
144.5
|
139.3
|
149.6
|
143
|
157.2
|
EBIT
1 |
91.59
|
81.58
|
94.05
|
84.3
|
90.66
|
87.72
|
89.57
|
Operating Margin
|
3.86%
|
3.17%
|
3.6%
|
3.17%
|
3.29%
|
3.15%
|
3.16%
|
Earnings before Tax (EBT)
|
-14.79
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-6.537
|
-45.75
|
45.69
|
44.57
|
53.46
|
63.42
|
68.27
|
Net margin
|
-0.28%
|
-1.78%
|
1.75%
|
1.68%
|
1.94%
|
2.28%
|
2.41%
|
EPS
2 |
-0.0600
|
-0.2600
|
0.2165
|
0.2156
|
0.2596
|
0.3054
|
0.3282
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/29/24
|
5/2/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
3,385
|
2,324
|
2,196
|
1,966
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
6.294
x
|
4.118
x
|
3.571
x
|
2.949
x
|
Free Cash Flow
1 |
-
|
137
|
198
|
234
|
-
|
ROE (net income / shareholders' equity)
|
-
|
1.77%
|
9.75%
|
9.01%
|
9.71%
|
ROA (Net income/ Total Assets)
|
-
|
0.22%
|
5.72%
|
6.4%
|
6.57%
|
Assets
1 |
-
|
-71,609
|
2,583
|
3,392
|
4,249
|
Book Value Per Share
2 |
-
|
4.960
|
9.090
|
10.20
|
11.70
|
Cash Flow per Share
2 |
-
|
1.790
|
0.4000
|
1.740
|
2.210
|
Capex
1 |
-
|
73.5
|
78
|
91.8
|
94.5
|
Capex / Sales
|
-
|
0.83%
|
0.73%
|
0.81%
|
0.77%
|
Announcement Date
|
8/28/23
|
2/29/24
|
-
|
-
|
-
|
Last Close Price
11.4
USD Average target price
16.23
USD Spread / Average Target +42.34% Consensus |
1st Jan change
|
Capi.
|
---|
| 0.00% | 1.95B | | -0.12% | 3.1B | | +18.78% | 1.78B | | +60.99% | 673M | | -19.32% | 419M | | -20.71% | 171M | | -14.74% | 134M | | +3.85% | 67.93M |
Home Healthcare Services
|